Ajer Jeffrey Robert bought VRDN
July 1, 2026 · Form 4 insider transaction
Ajer Jeffrey Robert bought 32,341 shares of Viridian Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
32,341
Price
$0.00
Total value
N/A
InsiderAjer Jeffrey Robert
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJuly 1, 2026
Filing dateJuly 2, 2026
Shares owned after32,341
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests in full upon the earlier to occur of (i) July 1, 2027 or (ii) the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service on the Board of Directors of the Issuer.